The Risk of Malignancy After Organ Transplantation
Authors:
R. Gürlich 1,2; J. Novotný 3; I. Stříž 4; E. Honsová 5; M. Oliverius 1; L. Janoušek 1; E. Pokorná 6; P. Maruna 7
Authors‘ workplace:
Klinika transplantační chirurgie IKEM, Praha
1; I. chirurgická klinika 1. LF UK a VFN, Praha
2; Onkologická klinika 1. LF UK a VFN, Praha
3; Oddělení klinické imunologie1. LF UK a VFN, Praha
4; Pracoviště klinické a transplantační patologie1. LF UK a VFN, Praha
5; Transplantcentrum IKEM, Praha
6; Ústav patologické fyziologie 1. LF UK, Praha
7
Published in:
Čas. Lék. čes. 2005; 144: 597-600
Category:
Review Article
Overview
Improvements in immunosuppressive therapy during the past decade brought about improvements of the long term tolerance of organ allografts. However, the long-term immunosuppressive therapy has an important limitation, because it can increase the risk of cardivascular diseases, infections and tumors. As compared with age-matched healthy population, organ-transplant recipients have an increased incidence of tumors.
Key words:
immunosuppression, tumor, transplantation.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Differential Diagnosis of Peripheral Neuropathy
- Latex Allergy – Report on Two Cases
- Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma The First Experience in the Czech Republic
- From the History of Endocrinology: Reminiscence of the Discovery of Adrenocortical Hormones